ESOMAR Asia Pacific 2018
13-15 May, Bangkok
Research Partnership is delighted to be attending the ESOMAR conference in Bangkok 13-15 May. The theme of this years’ conference is DRIVE: Data Research Insights Vision Excellence. The event will see an assembly of a range of brands and companies to the ESOMAR Asia Pacific stage to challenge the traditional, expand new thinking and take insights to the next level within the pharmaceutical industry.
Out of the shadows: Mental health in the Asia Pacific region
Published in eyeforpharma February 2018 by Marc Yates
Mental health has been a peripheral issue in emerging markets for a long time, despite the severe impact it can have, not only on those directly affected but also on families, carers, social cohesion, and economic development. Fortunately, mental health is starting to get more attention, but there is still a widespread tendency to stigmatise and discriminate against people suffering with a mental illness. They are often considered as dangerous and aggressive which in turn increases the social distance.
Is there an opportunity for pharma to do more? In the first of a series of articles exploring mental health in emerging markets we take an in-depth look at the situation in Asia where problems arising from ill mental health are the second largest contributor to years lost to disability (YL:D).
Live from Singapore: Going for growth - Maximising your return on insights in emerging markets
Healthcare market research in emerging markets is still evolving, so finding the insights you require and then maximising the return on those insights can be challenging. Download this complimentary webcast in which Emerging Markets experts Nicole Bender Moreira and Colin Tan will provide you with the critical success factors to ensure actionable primary research in emerging markets.
Navigating South Korea’s Healthcare Paradox
Published in eyeforpharma August 2017 by Marc Yates
In recent years, we have witnessed an explosion of interest among our pharmaceutical clients in conducting research in South Korea. Some emerging market analysts have suggested a ‘K’ should be added to BRIC, reflecting the country’s burgeoning economic status and its increasingly inclusion in global studies, not just regional Asia Pacific or emerging market studies. Indeed, there is ongoing debate about whether South Korea can still be considered ‘emerging’ as it is a growing player in the pharmaceutical industry in its own right.
As well as looking at South Korea’s healthcare outlook in more detail, in this article we also ask why the country lies at the extremes of two conflicting global health indicators – longest life expectancy and highest suicide rates.
Research Partnership’s Singapore team relocates to new office
We are delighted to announce that our Asia-Pacific team in Singapore has relocated to new premises.
As the regional office has continued to go from strength to strength, it became necessary to move the team of specialist researchers to new, larger offices in order to cope with increasing client demand.